ABOUT THE JOB
Our Team:
This role reports into the Global Medical Affairs Immunology team that is part of the Medical Affairs Specialty Care organization.
Our Medical Affairs function serves as a key strategic partner with commercial, regulatory, clinical, and market access on therapeutic solutions to support patients’ needs.
Within the Global Medical Affairs Immunology team, we are proud to support Sanofi’s unrelenting commitment to scientific exploration and to work on a first-in-class treatment and robust pipeline of potential new medicines for chronic dermatologic, respiratory, rheumatologic, and gastrointestinal diseases.
Main responsibilities:
The Global Medical Director will lead the development and implementation of the medical plan to support successful development and launch of Amlitelimab (anti-OX40L) in LCM indications.
This role, reporting into the Global Medical Lead, Amlitelimab, will work in close collaboration with other cross functional partners to develop and execute comprehensive lifecycle management, stakeholder engagement, data generation, and communication plans, ensuring excellence in medical launch readiness.
A summary of responsibilities include:
·Recognized as an internal subject matter expert and support Amlitelimab integrated evidence generation strategy, planning and execution worldwide across LCM indications
·Support data generation efforts by bridging global ambitions with local affiliates based on in-depth understanding
·Implement a strong partnership with local cross functional team, global & regional medical for appropriate communications strategy and KOL development
·Support development and training of local Medical teams
·Build professional working relationships with Global, Region and key markets, facilitate best practice sharing between global and countries
·Work effectively within the established corporate and industry compliance guidelines
ABOUT YOU
Education:
·Advanced degree in a scientific discipline (M.D., PhD or PharmD)
Experience:
·Significant immunology experience required (Dermatology, Respiratory, Rheumatology, and/or Gastroenterology
·Experience in clinical development and/or medical affairs on a global or regional level
·Experience in both clinical research and patient care
·Demonstrated ability to work effectively in a matrixed environment
·Proficient in public speaking
·5+ years of experience in the biotech or pharmaceutical industry or equivalent Immunology related experience
·Demonstrated commitment to innovation
·Experience working collaboratively and cross-functionally with medical, global brand teams, market research, sales, managed markets, sales operations, business development, regulatory, research & development, manufacturing, finance and legal
Skills and behaviors:
·Strong interpersonal, influencing and communication skills
·High aspiration to play an entrepreneurial role, cultivate innovative thinking, showing passion, compassion and agility
·Resilience and ability to challenges the status quo
·Strong business ethics
·Excellent organizational skills
·Ability to lead in an ambiguous environment across different functions and company cultures
·Analytic and synthetic capacity with the ability to understand and simplify
·Ability to chart a path and get from strategy to execution, successfully and quickly, amidst ambiguity and change
·Performance orientation and ability to work and deliver along agreed timeline
Sanofi Inc. and its U.S. affiliates are Equal Opportunity and Affirmative Action employers committed to a culturally diverse workforce. All qualified applicants will receive consideration for employment without regard to race; color; creed; religion; national origin; age; ancestry; nationality; marital, domestic partnership or civil union status; sex, gender, gender identity or expression; affectional or sexual orientation; disability; veteran or military status or liability for military status; domestic violence victim status; atypical cellular or blood trait; genetic information (including the refusal to submit to genetic testing) or any other characteristic protected by law.
#GD-SG
#LI-GZ
Cambridge, MA
As the specialty care global business unit of Sanofi, we are focused on rare diseases, rare blood disorders, multiple sclerosis, oncology and immunology. More than 30 years since we began, we remain just as committed to and passionate about advancing therapies that offer hope to patients and families.
Our approach is shaped by a long history of developing highly specialized treatments and forging close relationships with physician and patient communities. Founded as Genzyme in Boston in 1981, we rapidly grew to become one of the world’s leading biotechnology companies, recognized for our pioneering development of treatments for rare genetic disorders and our innovative contributions to medical science and biomanufacturing.
Genzyme became part of Sanofi in 2011. While continuing to focus on rare diseases, we also established ourselves as a leader in the field of multiple sclerosis. In 2016, our focus expanded to include Sanofi’s programs in oncology and immunology. In 2018, with the acquisitions of Bioverativ and Ablynx, we further expanded our focus to include rare blood disorders, bringing deep expertise in hematology.
Our ambition is to be the industry leader in specialty care. We currently provide more than 25 treatments to patients globally, with many potential new therapies being studied in clinical trials and in Sanofi laboratories.
Driven by our commitment to patients, we strive to develop strong relationships with our patient communities, listening to their perspectives so that we can truly understand their needs. These collaborations continue to guide and motivate us as we work to push the boundaries of medicine and technology to develop new and better therapies where none existed before.